# Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa

> **NCT01103063** · PHASE3 · TERMINATED · sponsor: **Pfizer** · enrollment: 2891 (actual)

## Conditions studied

- Intermittent Preventive Treatment In Pregnancy (IPTp)

## Interventions

- **DRUG:** Azithromycin plus chloroquine
- **DRUG:** sulfadoxine-pyrimethamine

## Key facts

- **NCT ID:** NCT01103063
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-11
- **Target enrollment:** 2891 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2015-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103063, "Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01103063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*